ClinVar Miner

Submissions for variant NM_000322.5(PRPH2):c.855C>A (p.Tyr285Ter)

dbSNP: rs62645938
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001854493 SCV002247282 pathogenic PRPH2-Related Disorders 2021-01-14 criteria provided, single submitter clinical testing This variant has been observed in individual(s) with pattern dystrophy (PMID: 9279751). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 98714). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr285*) in the PRPH2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 62 amino acid(s) of the PRPH2 protein. This variant disrupts the C-terminus of the PRPH2 protein. Other variant(s) that disrupt this region (p.Ser301Argfs*22) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.
Retina International RCV000085027 SCV000117163 not provided not provided no assertion provided not provided
Leiden Open Variation Database RCV000085027 SCV001745114 likely pathogenic not provided 2021-04-06 no assertion criteria provided curation Curator: Global Variome, with Curator vacancy. Submitter to LOVD: Manon Peeters.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.